The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 6, Issue MAY, 2014, Pages

  Kanekiyo, Takahisa ^a   Bu, Guojun ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Alzheimer's disease; amyloid ; Apolipoprotein E; clearance; degradation; endocytosis; LRP1; signaling pathway

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA SECRETASE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ACTIN POLYMERIZATION; ALZHEIMER DISEASE; BRAIN; BRAIN BLOOD VESSEL; ENDOCYTOSIS; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 84901341240     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00093     Document Type: Review

References (146)

1. Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., et al. (2005). Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 102, 13461-13466. doi: 10.1073/pnas.0503689102
2. Arelin, K., Kinoshita, A., Whelan, C. M., Irizarry, M. C., Rebeck, G. W., Strickland, D. K., et al. (2002). LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res. Mol. Brain Res. 104, 38-46. doi: 10.1016/S0169-328X(02)00203-6
3. Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., and Landreth, G. E. (2003). A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23, 2665-2674.
4. Basak, J. M., Verghese, P. B., Yoon, H., Kim, J., and Holtzman, D. M. (2012). Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aß uptake and degradation by astrocytes. J. Biol. Chem. 287, 13959-13971. doi: 10.1074/jbc.M111.288746
5. Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., et al. (2009). SRF and myocardin regulate LRP-mediated amyloid-ß clearance in brain vascular cells. Nat. Cell Biol. 11, 143-153. doi: 10.1038/ncb1819
6. Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., et al. (2012). Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516. doi: 10.1038/nature11087
7. Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y., and Huang, Y. (2012). Reducing human apolipoprotein E levels attenuates age-dependent Aß accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803-4811. doi: 10.1523/JNEUROSCI.0033-12.2012
8. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006). Alzheimer's disease. Lancet 368, 387-403. doi: 10.1016/S0140-6736(06)69113-7
9. Boucher, P., Gotthardt, M., Li, W. P., Anderson, R. G., and Herz, J. (2003). LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300, 329-332. doi: 10.1126/science.1082095
10. Bu, G. (2009). Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10, 333-344. doi: 10.1038/nrn2620
11. Bu, G., Maksymovitch, E. A., Nerbonne, J. M., and Schwartz, A. L. (1994). Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269, 18521-18528.
12. Cam, J. A., Zerbinatti, C. V., Li, Y., and Bu, G. (2005). Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the ß-amyloid precursor protein. J. Biol. Chem. 280, 15464-15470. doi: 10.1074/jbc.M500613200
13. Christianson, H. C., and Belting, M. (2013). Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol. doi: 10.1016/j.matbio.2013.10.004 [Epub ahead of print].
14. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. doi: 10.1126/science.8346443
15. Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., et al. (2012). ApoE-directed therapeutics rapidly clear ß-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506. doi: 10.1126/science.1217697
16. Crehan, H., Holton, P., Wray, S., Pocock, J., Guerreiro, R., and Hardy, J. (2012). Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology 217, 244-250. doi: 10.1016/j.imbio.2011.07.017
17. de la Torre, J. C. (2002). Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33, 1152-1162. doi: 10.1161/01.STR.0000014421.15948.67
18. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., et al. (2008). apoE isoform-specific disruption of amyloid ß peptide clearance from mouse brain. J. Clin. Invest. 118, 4002-4013. doi: 10.1172/JCI36663
19. Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., et al. (2004). LRP/amyloid ß-peptide interaction mediates differential brain efflux of Aß isoforms. Neuron 43, 333-344. doi: 10.1016/j.neuron.2004.07.017
20. Dedieu, S., and Langlois, B. (2008). LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells. Cell Adh. Migr. 2, 77-80. doi: 10.4161/cam.2.2.6374
21. Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A. III, Silverberg, G. D., Miller, M. C., et al. (2006). RAGE, LRP-1, and amyloid-ß protein in Alzheimer's disease. Acta Neuropathol. 112, 405-415. doi: 10.1007/s00401-006-0115-3
22. Duus, K., Hansen, E. W., Tacnet, P., Frachet, P., Arlaud, G. J., Thielens, N. M., et al. (2010). Direct interaction between CD91 and C1q. FEBS J. 277, 3526-3537. doi: 10.1111/j.1742-4658.2010.07762.x
23. Eimer, W. A., and Vassar, R. (2013). Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aß42 accumulation and Caspase-3 activation. Mol. Neurodegener. 8, 2. doi: 10.1186/1750-1326-8-2
24. Fanelli, F., Sepe, S., D'Amelio, M., Bernardi, C., Cristiano, L., Cimini, A., et al. (2013). Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol. Neurodegener. 8, 8. doi: 10.1186/1750-1326-8-8
25. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278, 1349-1356. doi: 10.1001/jama.1997.03550160069041
26. Fuentealba, R. A., Liu, Q., Zhang, J., Kanekiyo, T., Hu, X., Lee, J. M., et al. (2010). Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Aß42 uptake and lysosomal trafficking. PLoS ONE 5:e11884. doi: 10.1371/journal.pone.0011884
27. Fujiyoshi, M., Tachikawa, M., Ohtsuki, S., Ito, S., Uchida, Y., Akanuma, S., et al. (2011). Amyloid-ß peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier. J. Neurochem. 118, 407-415. doi: 10.1111/j.1471-4159.2011.07311.x
28. Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., et al. (2005). Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334. doi: 10.1016/j.cell.2005.08.032
29. Gaultier, A., Arandjelovic, S., Niessen, S., Overton, C. D., Linton, M. F., Fazio, S., et al. (2008). Regulation of tumor necrosis factor receptor-1 and the IKK-NF-?B pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood 111, 5316-5325. doi: 10.1182/blood-2007-12-127613
30. Gonias, S. L., and Campana, W. M. (2014). LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am. J. Pathol. 184, 18-27. doi: 10.1016/j.ajpath.2013.08.029
31. Gonias, S. L., Wu, L., and Salicioni, A. M. (2004). Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91, 1056-1064.
32. Gu, H., Wei, X., Monnot, A. D., Fontanilla, C. V., Behl, M., Farlow, M. R., et al. (2011). Lead exposure increases levels of ß-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice. Neurosci. Lett. 490, 16-20. doi: 10.1016/j.neulet.2010.12.017
33. Guerreiro, R. J., and Hardy, J. (2011). Alzheimer's disease genetics: lessons to improve disease modelling. Biochem. Soc. Trans. 39, 910-916. doi: 10.1042/BST0390910
34. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi: 10.1056/NEJMoa1211851
35. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
36. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093. doi: 10.1038/ng.440
37. Henderson, S. J., Andersson, C., Narwal, R., Janson, J., Goldschmidt, T. J., Appelkvist, P., et al. (2014). Sustained peripheral depletion of amyloid-ß with a novel form of neprilysin does not affect central levels of amyloid-ß. Brain 137, 553-564. doi: 10.1093/brain/awt308
38. Herz, J., and Bock, H. H. (2002). Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71, 405-434. doi: 10.1146/annurev.biochem.71.110601.135342
39. Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., and Stanley, K. K. (1988). Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127.
40. Herz, J., and Strickland, D. K. (2001). LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784. doi: 10.1172/JCI200113992
41. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J. C., Carrasquillo, M. M., et al. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435. doi: 10.1038/ng.803
42. Holtzman, D. M., Herz, J., and Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312. doi: 10.1101/cshperspect.a006312
43. Hooper, N. M. (2011). Glypican-1 facilitates prion conversion in lipid rafts. J. Neurochem. 116, 721-725. doi: 10.1111/j.1471-4159.2010.06936.x
44. Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., and Lee, J. M. (2009). Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-ß peptide. Proc. Natl. Acad. Sci. U.S.A. 106, 20324-20329. doi: 10.1073/pnas.0911281106
45. Hughes, S. R., Khorkova, O., Goyal, S., Knaeblein, J., Heroux, J., Riedel, N. G., et al. (1998). a2-macroglobulin associates with ß-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. U.S.A. 95, 3275-3280. doi: 10.1073/pnas.95.6.3275
46. Ito, S., Ueno, T., Ohtsuki, S., and Terasaki, T. (2010). Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-ß peptide(1-40) in mouse: involvement of an LRP-1-independent pathway. J. Neurochem. 113, 1356-1363. doi: 10.1111/j.1471-4159.2010.06708.x.
47. Jaeger, L. B., Dohgu, S., Hwang, M. C., Farr, S. A., Murphy, M. P., Fleegal-DeMotta, M. A., et al. (2009). Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-ß protein, and impairs cognition. J. Alzheimers Dis. 17, 553-570. doi: 10.3233/JAD-2009-1074
48. Jaeger, S., and Pietrzik, C. U. (2008). Functional role of lipoprotein receptors in Alzheimer's disease. Curr. Alzheimer Res. 5, 15-25. doi: 10.2174/156720508783884675
49. Jehle, A. W., Gardai, S. J., Li, S., Linsel-Nitschke, P., Morimoto, K., Janssen, W. J., et al. (2006). ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages. J. Cell Biol. 174, 547-556. doi: 10.1083/jcb.200601030
50. Jen, A., Parkyn, C. J., Mootoosamy, R. C., Ford, M. J., Warley, A., Liu, Q., et al. (2010). Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4. J. Cell Sci. 123, 246-255. doi: 10.1242/jcs.058099
51. Kanekiyo, T., and Bu, G. (2009). Receptor-associated protein interacts with amyloid-ß peptide and promotes its cellular uptake. J. Biol. Chem. 284, 33352-33359. doi: 10.1074/jbc.M109.015032
52. Kanekiyo, T., Cirrito, J. R., Liu, C. C., Shinohara, M., Li, J., Schuler, D. R., et al. (2013). Neuronal clearance of amyloid-ß by endocytic receptor LRP1. J. Neurosci. 33, 19276-19283. doi: 10.1523/JNEUROSCI.3487-13.2013
53. Kanekiyo, T., Liu, C. C., Shinohara, M., Li, J., and Bu, G. (2012). LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-ß. J. Neurosci. 32, 16458-16465. doi: 10.1523/JNEUROSCI.3987-12.2012
54. Kanekiyo, T., Xu, H., and Bu, G. (2014). ApoE and Aß in Alzheimer's disease: accidental encounters or partners? Neuron 81, 740-754. doi: 10.1016/j.neuron.2014.01.045
55. Kanekiyo, T., Zhang, J., Liu, Q., Liu, C. C., Zhang, L., and Bu, G. (2011). Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-ß uptake. J. Neurosci. 31, 1644-1651. doi: 10.1523/JNEUROSCI.5491-10.2011
56. Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., et al. (2000). Modulation of amyloid ß-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest. 106, 1159-1166. doi: 10.1172/JCI11013
57. Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., et al. (2009). Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A ß clearance. Neuron 64, 632-644. doi: 10.1016/j.neuron.2009.11.013
58. Kim, J., Jiang, H., Park, S., Eltorai, A. E., Stewart, F. R., Yoon, H., et al. (2011). Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-ß amyloidosis. J. Neurosci. 31, 18007-18012. doi: 10.1523/JNEUROSCI.3773-11.2011
59. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., et al. (2004). Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-ß peptides. Nat. Med. 10, 719-726. doi: 10.1038/nm1058
60. Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., et al. (1995). LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted ß-amyloid precursor protein and mediates its degradation. Cell 82, 331-340. doi: 10.1016/0092-8674(95)90320-8
61. Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V., and Brown, M. S. (1989). Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 86, 5810-5814. doi: 10.1073/pnas.86.15.5810
62. Krieger, M., and Herz, J. (1994). Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601-637. doi: 10.1146/annurev.bi.63.070194.003125
63. LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., et al. (2000). Apolipoprotein E receptors mediate the effects of ß-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974-33980. doi: 10.1074/jbc.M000602200
64. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099. doi: 10.1038/ng.439
65. Laporte, V., Lombard, Y., Levy-Benezra, R., Tranchant, C., Poindron, P., and Warter, J. M. (2004). Uptake of Aß 1-40- and Aß 1-42-coated yeast by microglial cells: a role for LRP. J. Leukoc. Biol. 76, 451-461. doi: 10.1189/jlb.1203620
66. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-ß oligomers. Nature 457, 1128-1132. doi: 10.1038/nature07761
67. Lee, C. Y., Tse, W., Smith, J. D., and Landreth, G. E. (2012). Apolipoprotein E promotes ß-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287, 2032-2044. doi: 10.1074/jbc.M111.295451
68. Li, J., Kanekiyo, T., Shinohara, M., Zhang, Y., LaDu, M. J., Xu, H., et al. (2012). Differential regulation of amyloid-ß endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J. Biol. Chem. 287, 44593-44601. doi: 10.1074/jbc.M112.420224
69. Li, Y., Lu, W., Marzolo, M. P., and Bu, G. (2001). Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates. J. Biol. Chem. 276, 18000-18006. doi: 10.1074/jbc.M101589200
70. Li, Y., Marzolo, M. P., van Kerkhof, P., Strous, G. J., and Bu, G. (2000). The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J. Biol. Chem. 275, 17187-17194. doi: 10.1074/jbc.M000490200
71. Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., and Strickland, D. K. (2008). LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918. doi: 10.1152/physrev.00033.2007
72. Liu, C. C., Kanekiyo, T., Xu, H., and Bu, G. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106-118. doi: 10.1038/nrneurol.2012.263
73. Liu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., et al. (2010). Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J. Neurosci. 30, 17068-17078. doi: 10.1523/JNEUROSCI.4067-10.2010
74. Liu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H. S., Wang, B., Cole, S. L., et al. (2007). Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56, 66-78. doi: 10.1016/j.neuron.2007.08.008
75. Liu, Q., Zhang, J., Tran, H., Verbeek, M. M., Reiss, K., Estus, S., et al. (2009). LRP1 shedding in human brain: roles of ADAM10 and ADAM17. Mol. Neurodegener. 4, 17. doi: 10.1186/1750-1326-4-17
76. Maier, W., Bednorz, M., Meister, S., Roebroek, A., Weggen, S., Schmitt, U., et al. (2013). LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype. Mol. Neurodegener. 8, 25. doi: 10.1186/1750-1326-8-25
77. Mandrekar, S., Jiang, Q., Lee, C. Y., Koenigsknecht-Talboo, J., Holtzman, D. M., and Landreth, G. E. (2009). Microglia mediate the clearance of soluble Aß through fluid phase macropinocytosis. J. Neurosci. 29, 4252-4262. doi: 10.1523/JNEUROSCI.5572-08.2009
78. Mantuano, E., Jo, M., Gonias, S. L., and Campana, W. M. (2010). Low density lipoprotein receptor-related protein (LRP1) regulates Rac1 and RhoA reciprocally to control Schwann cell adhesion and migration. J. Biol. Chem. 285, 14259-14266. doi: 10.1074/jbc.M109.085126
79. Marques, F., Sousa, J. C., Sousa, N., and Palha, J. A. (2013). Blood-brain-barriers in aging and in Alzheimer's disease. Mol. Neurodegener. 8, 38. doi: 10.1186/1750-1326-8-38
80. Matsui, T., Ingelsson, M., Fukumoto, H., Ramasamy, K., Kowa, H., Frosch, M. P., et al. (2007). Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res. 1161, 116-123. doi: 10.1016/j.brainres.2007.05.050
81. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., et al. (2010). Decreased clearance of CNS ß-amyloid in Alzheimer's disease. Science 330, 1774. doi: 10.1126/science.1197623
82. May, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., et al. (2004). Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872-8883. doi: 10.1128/MCB.24.20.8872-8883.2004
83. Mayor, S., and Pagano, R. E. (2007). Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 603-612. doi: 10.1038/nrm2216
84. Mucke, L., and Selkoe, D. J. (2012). Neurotoxicity of amyloid ß-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2, a006338. doi: 10.1101/cshperspect.a006338
85. Muratoglu, S. C., Mikhailenko, I., Newton, C., Migliorini, M., and Strickland, D. K. (2010). Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-ß in endosomes and regulates activation of the MAPK pathway. J. Biol. Chem. 285, 14308-14317. doi: 10.1074/jbc.M109.046672
86. Naj, A. C., Jun, G., Beecham, G. W., Wang, L. S., Vardarajan, B. N., Buros, J., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43, 436-441. doi: 10.1038/ng.801
87. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166. doi: 10.1016/0006-8993(91)91092-F
88. Narita, M., Holtzman, D. M., Schwartz, A. L., and Bu, G. (1997). a2-macroglobulin complexes with and mediates the endocytosis of ß-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69, 1904-1911. doi: 10.1046/j.1471-4159.1997.69051904.x
89. Nazer, B., Hong, S., and Selkoe, D. J. (2008). LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-ß peptide in a blood-brain barrier in vitro model. Neurobiol. Dis. 30, 94-102. doi: 10.1016/j.nbd.2007.12.005
90. Neels, J. G., van Den Berg, B. M., Lookene, A., Olivecrona, G., Pannekoek, H., and van Zonneveld, A. J. (1999). The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J. Biol. Chem. 274, 31305-31311. doi: 10.1074/jbc.274.44.31305
91. Obermoeller-McCormick, L. M., Li, Y., Osaka, H., FitzGerald, D. J., Schwartz, A. L., and Bu, G. (2001). Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein. J. Cell. Sci. 114, 899-908.
92. Pflanzner, T., Janko, M. C., André-Dohmen, B., Reuss, S., Weggen, S., Roebroek, A. J., et al. (2011). LRP1 mediates bidirectional transcytosis of amyloid-ß across the blood-brain barrier. Neurobiol. Aging 32, 2323.e1-2323.e11. doi: 10.1016/j.neurobiolaging.2010.05.025
93. Qiu, Z., Strickland, D. K., Hyman, B. T., and Rebeck, G. W. (1999). a2-macroglobulin enhances the clearance of endogenous soluble ß-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J. Neurochem. 73, 1393-1398. doi: 10.1046/j.1471-4159.1999.0731393.x
94. Qosa, H., Abuznait, A. H., Hill, R. A., and Kaddoumi, A. (2012). Enhanced brain amyloid-ß clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease. J. Alzheimers Dis. 31, 151-165. doi: 10.3233/JAD-2012-120319
95. Quinn, K. A., Grimsley, P. G., Dai, Y. P., Tapner, M., Chesterman, C. N., and Owensby, D. A. (1997). Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J. Biol. Chem. 272, 23946-23951. doi: 10.1074/jbc.272.38.23946
96. Rebeck, G. W., Harr, S. D., Strickland, D. K., and Hyman, B. T. (1995). Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the a 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217. doi: 10.1002/ana.410370212
97. Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., et al. (2007). The LXR agonist TO901317 selectively lowers hippocampal Aß42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Neurosci. 34, 621-628. doi: 10.1016/j.mcn.2007.01.011
98. Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39, 168-177. doi: 10.1038/ng1943
99. Rosen, C., Hansson, O., Blennow, K., and Zetterberg, H. (2013). Fluid biomarkers in Alzheimer's disease - current concepts. Mol. Neurodegener. 8, 20. doi: 10.1186/1750-1326-8-20
100. Rushworth, J. V., Griffiths, H. H., Watt, N. T., and Hooper, N. M. (2013). Prion protein-mediated toxicity of amyloid-ß oligomers requires lipid rafts and the transmembrane LRP1. J. Biol. Chem. 288, 8935-8951. doi: 10.1074/jbc.M112.400358
101. Sagare, A., Deane, R., Bell, R. D., Johnson, B., Hamm, K., Pendu, R., et al. (2007). Clearance of amyloid-ß by circulating lipoprotein receptors. Nat. Med. 13, 1029-1031. doi: 10.1038/nm1635
102. Sagare, A. P., Bell, R. D., Srivastava, A., Sengillo, J. D., Singh, I., Nishida, Y., et al. (2013a). A lipoprotein receptor cluster IV mutant preferentially binds amyloid-, and regulates its clearance from the mouse brain. J. Biol. Chem. 288, 15154-15166. doi: 10.1074/jbc.M112.439570
103. Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., et al. (2013b). Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 4, 2932. doi: 10.1038/ncomms3932
104. Sagare, A. P., Bell, R. D., and Zlokovic, B. V. (2013c). Neurovascular defects, and faulty amyloid-ß vascular clearance in Alzheimer's disease. J. Alzheimers Dis. 33(Suppl. 1), S87-S100. doi: 10.3233/JAD-2012-129037
105. Saido, T., and Leissring, M. A. (2012). Proteolytic degradation of amyloid ß-protein. Cold Spring Harb. Perspect. Med. 2, a006379. doi: 10.1101/cshperspect.a006379
106. Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., and Weller, R. O. (2006). Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol. 238, 962-974. doi: 10.1016/j.jtbi.2005.07.005
107. Sehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., et al. (2012). Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. U.S.A. 109, 3510-3515. doi: 10.1073/pnas.1112209109
108. Shi, Y., Mantuano, E., Inoue, G., Campana, W. M., and Gonias, S. L. (2009). Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci. Signal. 2, ra18. doi: 10.1126/scisignal.2000188
109. Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., et al. (2000). Clearance of Alzheimer's amyloid-ß1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499. doi: 10.1172/JCI10498
110. Shinohara, M., Fujioka, S., Murray, M. E., Wojtas, A., Baker, M., Rovelet-Lecrux, A., et al. (2014). Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. Brain 137, 1533-1549. doi: 10.1093/brain/awu046
111. Shinohara, M., Petersen, R. C., Dickson, D. W., and Bu, G. (2013). Brain regional correlation of amyloid-ßwith synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-ß accumulation. Acta Neuropathol. 125, 535-547. doi: 10.1007/s00401-013-1086-9
112. Shinohara, M., Sato, N., Kurinami, H., Takeuchi, D., Takeda, S., Shimamura, M., et al. (2010). Reduction of brain ß-amyloid (Aß) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Aß clearance. J. Biol. Chem. 285, 22091-22102. doi: 10.1074/jbc.M110.102277
113. Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., et al. (2010). Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J. Neuropathol. Exp. Neurol. 69, 1034-1043. doi: 10.1097/NEN.0b013e3181f46e25
114. Singh, I., Sagare, A. P., Coma, M., Perlmutter, D., Gelein, R., Bell, R. D., et al. (2013). Low levels of copper disrupt brain amyloid-ß homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. U.S.A. 110, 14771-14776. doi: 10.1073/pnas.1302212110
115. Song, H. L., Shim, S., Kim, D. H., Won, S. H., Joo, S., Kim, S., et al. (2014). ß-Amyloid is transmitted via neuronal connections along axonal membranes. Ann. Neurol. 75, 88-97. doi: 10.1002/ana.24029
116. Spuch, C., Ortolano, S., and Navarro, C. (2012). LRP-1 and LRP-2 receptors function in the membrane neuron. trafficking mechanisms and proteolytic processing in Alzheimer's disease. Front. Physiol. 3:269. doi: 10.3389/fphys.2012.00269
117. Strickland, D. K., Ashcom, J. D., Williams, S., Burgess, W. H., Migliorini, M., and Argraves, W. S. (1990). Sequence identity between the a 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265, 17401-17404.
118. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., et al. (1993). Binding of human apolipoprotein E to synthetic amyloid ß peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102. doi: 10.1073/pnas.90.17.8098
119. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2013). The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2013.09.010 [Epub ahead of print].
120. Tamaki, C., Ohtsuki, S., and Terasaki, T. (2007). Insulin facilitates the hepatic clearance of plasma amyloid ß-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes. Mol. Pharmacol. 72, 850-855. doi: 10.1124/mol.107.036913
121. Taylor, D. R., and Hooper, N. M. (2006). The prion protein and lipid rafts. Mol. Membr. Biol. 23, 89-99. doi: 10.1080/09687860500449994
122. Taylor, D. R., and Hooper, N. M. (2007). The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402, 17-23. doi: 10.1042/BJ20061736
123. Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J. Å., Holtzman, D. M., et al. (2011). Critical role of astroglial apolipoprotein E and liver X receptor-a expression for microglial Aß phagocytosis. J. Neurosci. 31, 7049-7059. doi: 10.1523/JNEUROSCI.6546-10.2011
124. Thies, W., and Bleiler, L. (2013). 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 9, 208-245. doi: 10.1016/j.jalz.2013.02.003
125. Torres, M., Jimenez, S., Sanchez-Varo, R., Navarro, V., Trujillo-Estrada, L., Sanchez-Mejias, E., et al. (2012). Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Aß in transgenic APP/PS1 hippocampus. Mol. Neurodegener. 7, 59. doi: 10.1186/1750-1326-7-59
126. Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., et al. (2000). Modulation of ß-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275, 7410-7415. doi: 10.1074/jbc.275.10.7410
127. van Kerkhof, P., Lee, J., McCormick, L., Tetrault, E., Lu, W., Schoenfish, M., et al. (2005). Sorting nexin 17 facilitates LRP recycling in the early endosome. EMBO J. 24, 2851-2861. doi: 10.1038/sj.emboj.7600756
128. Vanmierlo, T., Rutten, K., Dederen, J., Bloks, V. W., van Vark-van der Zee, L. C., Kuipers, F., et al. (2011). Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol. Aging 32, 1262-1272. doi: 10.1016/j.neurobiolaging.2009.07.005
129. Verghese, P. B., Castellano, J. M., Garai, K., Wang, Y., Jiang, H., Shah, A., et al. (2013). ApoE influences amyloid-ß (Aß) clearance despite minimal apoE/Aß association in physiological conditions. Proc. Natl. Acad. Sci. U.S.A. 110, E1807-E1816. doi: 10.1073/pnas.1220484110
130. Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C. Y., and Rodriguez, J. J. (2010). Astrocytes in Alzheimer's disease. Neurotherapeutics 7, 399-412. doi: 10.1016/j.nurt.2010.05.017
131. von Arnim, C. A., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., et al. (2005). The low density lipoprotein receptor-related protein (LRP) is a novel ß-secretase (BACE1) substrate. J. Biol. Chem. 280, 17777-17785. doi: 10.1074/jbc.M414248200
132. Walker, J. R., Pacoma, R., Watson, J., Ou, W., Alves, J., Mason, D. E., et al. (2013). Enhanced proteolytic clearance of plasma Aß by peripherally administered neprilysin does not result in reduced levels of brain Aß in mice. J. Neurosci. 33, 2457-2464. doi: 10.1523/JNEUROSCI.3407-12.2013
133. Wang, H., Ren, C. H., Gunawardana, C. G., and Schmitt-Ulms, G. (2013). Overcoming barriers and thresholds - signaling of oligomeric Aß through the prion protein to Fyn. Mol. Neurodegener. 8, 24. doi: 10.1186/1750-1326-8-24
134. Weaver, A. M., Hussaini, I. M., Mazar, A., Henkin, J., and Gonias, S. L. (1997). Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J. Biol. Chem. 272, 14372-14379. doi: 10.1074/jbc.272.22.14372
135. Wilhelmus, M. M., Otte-Höller, I., van Triel, J. J., Veerhuis, R., Maat-Schieman, M. L., Bu, G., et al. (2007). Lipoprotein receptor-related protein-1 mediates amyloid-ß-mediated cell death of cerebrovascular cells. Am. J. Pathol. 171, 1989-1999. doi: 10.2353/ajpath.2007.070050
136. Wilsie, L. C., and Orlando, R. A. (2003). The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J. Biol. Chem. 278, 15758-15764. doi: 10.1074/jbc.M208786200
137. Winkler, K., Scharnagl, H., Tisljar, U., Hoschützky, H., Friedrich, I., Hoffmann, M. M., et al. (1999). Competition of Aß amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J. Lipid Res. 40, 447-455.
138. Wu, L., and Gonias, S. L. (2005). The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts. J. Cell. Biochem. 96, 1021-1033. doi: 10.1002/jcb.20596
139. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., et al. (2003). Adult mouse astrocytes degrade amyloid-ß in vitro and in situ. Nat. Med. 9, 453-457. doi: 10.1038/nm838
140. Yamada, K., Hashimoto, T., Yabuki, C., Nagae, Y., Tachikawa, M., Strickland, D. K., et al. (2008). The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid ß peptides in an in vitro model of the blood-brain barrier cells. J. Biol. Chem. 283, 34554-34562. doi: 10.1074/jbc.M801487200
141. Yu, C., Nwabuisi-Heath, E., Laxton, K., and Ladu, M. J. (2010). Endocytic pathways mediating oligomeric Aß42 neurotoxicity. Mol. Neurodegener. 5, 19. doi: 10.1186/1750-1326-5-19
142. Yuyama, K., and Yanagisawa, K. (2009). Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease. J. Neurochem. 109, 1250-1260. doi: 10.1111/j.1471-4159.2009.06046.x
143. Zerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., et al. (2006). Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aß42 accumulation in amyloid model mice. J. Biol. Chem. 281, 36180-36186. doi: 10.1074/jbc.M604436200
144. Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738. doi: 10.1038/nrn3114
145. Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., and Winkler, E. A. (2010). Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid ß-peptide elimination from the brain. J. Neurochem. 115, 1077-1089. doi: 10.1111/j.1471-4159.2010.07002.x
146. Zurhove, K., Nakajima, C., Herz, J., Bock, H. H., and May, P. (2008). Gamma-secretase limits the inflammatory response through the processing of LRP1. Sci. Signal. 1, ra15. doi: 10.1126/scisignal.1164263